Inventor · disambiguated record
Stephen Gately
Also filed as: GATELY STEPHEN · GATELY STEPHEN T
30 granted patents·16 pending applications·330 citations·filing 1996–2022
96Inventor score
Top patents by PatentIndex Score
46 records- 0194US6916800B2Combination therapy including a matrix metalloproteinase inhibitor and an antineoplastic agentPFIZER·Filed 2004·Granted Jul 12, 2005·53 cites·14 claims
- 0291US6858598B1Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasiaSEARLE & CO·Filed 1999·Granted Feb 22, 2005·97 cites·24 claims
- 0386US6833373B1Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasiaSEARLE & CO·Filed 1999·Granted Dec 21, 2004·64 cites·3 claims
- 0485US11555039B2Amide compounds as kinase inhibitors, compositions and methods of treatmentTRANSLATIONAL DRUG DEV LLC·Filed 2020·Granted Jan 17, 2023·1 cites·19 claims
- 0584US11236052B2Aminobenzimidazole derivatives, treatments, and methods of inhibiting histone deacetylaseTRANSLATIONAL DRUG DEV LLC·Filed 2018·Granted Feb 1, 2022·4 cites·20 claims
- 0684US10392402B2Heterocyclic compounds as kinase inhibitorsTRANSLATIONAL DRUG DEV LLC·Filed 2016·Granted Aug 27, 2019·4 cites·20 claims
- 0781US9125901B24-(benzimidazol-2-ylamino)benzamide derivatives and salts or solvates thereofWANG TONG·Filed 2010·Granted Sep 8, 2015·5 cites·8 claims
- 0879US8987468B2Compounds, pharmaceutical compositions and methods of use of hydroxamic acid derivativesWANG TONG·Filed 2009·Granted Mar 24, 2015·1 cites·7 claims
- 0976US10633393B2Heterocyclic compounds as kinase inhibitorsTRANSLATIONAL DRUG DEV LLC·Filed 2019·Granted Apr 28, 2020·1 cites·24 claims
- 1075US11420947B2(S)-n-hydroxy-2-(2-(4-methoxyphenyl)butanamido)thiazole-5-carboxamide and pharmaceutically acceptable salts thereofTRANSLATIONAL DRUG DEV LLC·Filed 2021·Granted Aug 23, 2022·0 cites·8 claims
- 1175US5801012AMethods and compositions for generating angiostatinUNIV NORTHWESTERN·Filed 1996·Granted Sep 1, 1998·35 cites·4 claims
- 1274US10131654B2Pyrazole compounds and methods of use thereofTRANSLATIONAL DRUG DEV LLC·Filed 2014·Granted Nov 20, 2018·1 cites·18 claims
- 1372US6689787B1Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasiaSEARLE & CO·Filed 1999·Granted Feb 10, 2004·33 cites·15 claims
- 1472US6576609B1Methods and compositions for generating angiostatinUNIV NORTHWESTERN·Filed 1997·Granted Jun 10, 2003·24 cites·14 claims
- 1571US10544100B2Autophagy inhibitorsTRANSLATIONAL GENOMICS RES INST·Filed 2018·Granted Jan 28, 2020·1 cites·14 claims
- 1671US9221773B2Benzamide derivativesWANG TONG·Filed 2010·Granted Dec 29, 2015·2 cites·7 claims
- 1770US2023143583A1Amide compounds as kinase inhibitors, compositions and methods of treatmentTRANSLATIONAL DRUG DEV LLC·Filed 2022·Application pending·0 cites
- 1869US11780816B2Aminobenzimidazole derivatives, treatments, and methods of inhibiting histone deacetylaseTRANSLATIONAL DRUG DEV LLC·Filed 2022·Granted Oct 10, 2023·0 cites·20 claims
- 1969US2022402884A1(s)-n-hydroxy-2-(2-(4-methoxyphenyl)butanamido)thiazole-5-carboxamide and pharmaceutically acceptable salts thereofTRANSLATIONAL DRUG DEV LLC·Filed 2022·Application pending·0 cites
- 2067US9447050B2Solid forms of curcuminGATELY STEPHEN T·Filed 2012·Granted Sep 20, 2016·1 cites·18 claims
- 2166US9464059B2Benzamide derivativesTHE TRANSLATION GENOMICS RES INST·Filed 2015·Granted Oct 11, 2016·1 cites·20 claims
- 2263US10590088B24-(benzimidazol-2-ylamino)benzamide derivatives and methods of synthesis thereofTRANSLATIONAL DRUG DEV LLC·Filed 2018·Granted Mar 17, 2020·0 cites·17 claims
- 2362US7964738B2Pharmaceutical compositions and methods of use of lipophilic, silicon-substituted, cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs and derivativesSILAMED INC·Filed 2006·Granted Jun 21, 2011·2 cites·6 claims
- 2461US2004234624A1Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasiaFiled 2004·Application pending·0 cites
- 2560US12076401B2Benzamide and active compound compositions and methods of useTRANSLATIONAL DRUG DEV LLC·Filed 2020·Granted Sep 3, 2024·0 cites·20 claims
- 2660US10584119B2Pyrazole compounds and methods of use thereofTRANSLATIONAL DRUG DEV LLC·Filed 2018·Granted Mar 10, 2020·0 cites·20 claims
- 2757US10807966B2Heterocyclic compounds as kinase inhibitorsTRANSLATIONAL DRUG DEV LLC·Filed 2017·Granted Oct 20, 2020·0 cites·9 claims
- 2857US10780080B2Benzamide and active compound compositions and methods of useTRANSLATIONAL DRUG DEV LLC·Filed 2017·Granted Sep 22, 2020·0 cites·8 claims
- 2957US2020255448A1Heterocyclic compounds as kinase inhibitorsTRANSLATIONAL DRUG DEVELOPMENT LLC·Filed 2020·Application pending·0 cites
- 3056US9381196B2Compounds, pharmaceutical compositions and methods of use of hydroxamic acid derivativesTRANSLATIONAL GENOMICS RES INST·Filed 2015·Granted Jul 5, 2016·0 cites·7 claims
- 3155US10881733B2Benzamide and active compound compositions and methods of useTRANSLATIONAL DRUG DEV LLC·Filed 2016·Granted Jan 5, 2021·0 cites·17 claims
- 3255US2005037090A1Combination therapy including a cyclooxygenase-2 inhibitor and an antineoplastic agentFiled 2004·Application pending·0 cites
- 3354US2016362382A1Benzamide derivativesTHE TRANSLATIONAL GENOMICS RES INST·Filed 2016·Application pending·0 cites
- 3453US2010069330A1Pharmaceutical Compositions and Methods for Preparing and Using Lipophilic Organosulfur Cell Proliferation InhibitorsGATELY STEPHEN·Filed 2009·Application pending·0 cites
- 3551US2022184040A1Method of treating malignant rhabdoid tumor of the ovary and small cell cancer of the ovary of the hypercalcemic typeTRANSLATIONAL DRUG DEV LLC·Filed 2020·Application pending·0 cites
- 3650US2006099671A1Methods and compositions for generating angiostatinUNIV NORTHWESTERN·Filed 2005·Application pending·0 cites
- 3748US9221760B2Autophagy inhibitorsMACKEIGAN JEFFREY PAUL·Filed 2012·Granted Dec 29, 2015·0 cites·1 claims
- 3848US2016137607A1Autophagy InhibitorsVAN ANDEL RES INST·Filed 2015·Application pending·0 cites
- 3944US2009054369A1Pharmaceutical compositions of silicon-containing substituted adenosine nucleoside amide analogsRND PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 4044US2002103141A1Antiangiogenic combination therapy for the treatment of cancerFiled 2001·Application pending·0 cites
- 4144US2017000784A1Autophagy InhibitorsVAN ANDEL RES INST·Filed 2014·Application pending·0 cites
- 4240US10738007B2Amide compounds as kinase inhibitors, compositions and methods of treatmentTRANSLATIONAL DRUG DEVELOPMENT LLC·Filed 2019·Granted Aug 11, 2020·0 cites·19 claims
- 4339US9532984B2Therapeutic combination for cancer treatmentGATELY STEPHEN T·Filed 2012·Granted Jan 3, 2017·0 cites·20 claims
- 4439US2009306015A1Pharmaceutical compositions and methods of use of highly lipophilic sulfhydryl compoundsSILAMED INC·Filed 2006·Application pending·0 cites
- 4537US2019040017A1Aminobenzimidazole derivativesTRANSLATIONAL DRUG DEV LLC·Filed 2016·Application pending·0 cites
- 4636US2006099652A1IL 13 receptor alpha 2 antibody and methods of useNEOPHARM INC·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stephen Gately files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →